Digestive Diseases
Centre of Excellence

Adalimumab Clearance, rather than Trough Level,May Have Greatest Relevance to Crohn’s Disease Therapeutic Outcomes Assessed Clinically and Endoscopically.

Published 12 Aug 2021 | Written By Cadence

Lower adalimumab clearance is associated with an improved clinical outcome for patients with Crohn’s disease and may be a superior pharmacokinetic measure than concentration.

Keep reading

See all
img
Genetic variation in IL28B predicts interferon-induced clearance of HCV
  • 12 Aug 2021

A recently published article outlining Genetic variation in IL28B predicts interferon-induced clearance of HCV